BHARAT IMMUNOLOGICALS (India) Valuation

BHARAT IMMUNOLOGICALS latest Real Value cannot be determined due to lack of data. The recent price of BHARAT IMMUNOLOGICALS is 0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. This module approximates value of BHARAT IMMUNOLOGICALS from examining the firm fundamentals such as Price to Earning of 262.88  and Return On Asset of (9.86)  as well as evaluating its technical indicators and Probability Of Bankruptcy. In general, we favor to invest in undervalued equities and to trade away overvalued equities since at some future date instruments prices and their ongoing real values will grow together.
Horizon     30 Days    Login   to change
BHARAT IMMUNOLOGICALS BIOLOG is number one stock in price to sales category among related companies. It is number one stock in price to book category among related companies fabricating about  2.47  of Price to Book per Price to Sales.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also Trending Equities. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Search macroaxis.com